2-amino-5-(ethylsulfonyl)phenol

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: 2-amino-5-(ethylsulfonyl)phenol
• 英文别名: 2-amino-5-ethylsulfonylphenol
• 化学式: C₈H₁₁NO₃S
• 分子量: 201.246
• InChiKey: TYFGMFQLFGWYBY-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  0.5
• 重原子数：
  13
• 可旋转键数：
  2
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.25
• 拓扑面积：
  88.8
• 氢给体数：
  2
• 氢受体数：
  4

反应信息

• 作为反应物：
  描述：

  2-amino-5-(ethylsulfonyl)phenol 、 4-乙氧基苯基硫氰酸酯 在 双氧水 、 lithium hydroxide 作用下， 生成 N-(4-ethoxyphenyl)-6-ethylsulfonyl-1,3-benzoxazol-2-amine
  参考文献：
  名称：

  Hit to lead SAR study on benzoxazole derivatives for an NPY Y5 antagonist

  摘要：

  We report a hit to lead study on a novel benzoxazole NPY Y5 antagonist. Starting from HTS hit 1, structure-activity relationships were developed. Compound 12 showed reduction of food intake and a tendency to suppress body weight gain over the 21-day experimental period. (C) 2012 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2012.01.027
• 作为产物：
  描述：

  5-氟-2-硝基苯酚 在 palladium on carbon 、 氢气 作用下， 以 industrial methylated spirit 、 二甲基亚砜 为溶剂， 反应 19.0h， 生成 2-amino-5-(ethylsulfonyl)phenol
  参考文献：
  名称：

  Discovery of 2-Arylbenzoxazoles as Upregulators of Utrophin Production for the Treatment of Duchenne Muscular Dystrophy

  摘要：

  A series of novel 2-arylbenzoxazoles that upregulate the production of utrophin in murine H2K cells, as assessed using a luciferase reporter linked assay, have been identified. This compound class appears to hold considerable promise as a potential treatment for Duchenne muscular dystrophy. Following the delineation of structure-activity relationships in the series, a number of potent upregulators were identified, and preliminary ADME evaluation is described. These studies have resulted in the identification of 1, a compound that has been progressed to clinical trials.

  DOI：

  10.1021/jm200135z

文献信息

• Solid phase-assisted synthesis and screening of a small library of N-(4-hydroxyphenyl)retinamide (4-HPR) analogs
  作者：Serena M. Mershon、Allyson L. Anding、Jason S. Chapman、Margaret Clagett-Dame、Laura A. Stonerock、Robert W. Curley

  DOI：10.1016/j.bmcl.2006.10.050

  日期：2007.2

  Using solid phase-assisted synthesis and purification, a 49 member library of analogs of the main mammary tumor chemopreventive retinoid N-(4-hydroxyphenyl)retinamide (4-HPR) has been prepared. After prescreening for growth inhibitory activity in human mammary tumor cells (MCF-7) in culture, most of those analogs which showed activity (12 of them) were assayed for apoptosis-inducing activity in the MCF-7 cells. At least 3 of the analogs (13, 24, and 28) showed activity approaching that of 4-HPR. (c) 2006 Elsevier Ltd. All rights reserved.
• Verfahren zum Färben linearer Polyamide in der Masse mit Salzen von 1:2 Chromkomplex-monoazofarbstoffen; die damit erzeugten Fasern
  申请人：CIBA-GEIGY AG

  公开号：EP0000331B1

  公开（公告）日：1983-12-28
• US4263197A
  申请人：——

  公开号：US4263197A

  公开（公告）日：1981-04-21
• Discovery of 2-Arylbenzoxazoles as Upregulators of Utrophin Production for the Treatment of Duchenne Muscular Dystrophy
  作者：Daniel R. Chancellor、Kay E. Davies、Olivier De Moor、Colin R. Dorgan、Peter D. Johnson、Adam G. Lambert、Daniel Lawrence、Cristina Lecci、Carole Maillol、Penny J. Middleton、Gary Nugent、Séverine D. Poignant、Allyson C. Potter、Paul D. Price、Richard J. Pye、Richard Storer、Jonathon M. Tinsley、Renate van Well、Richard Vickers、Julia Vile、Fraser J. Wilkes、Francis X. Wilson、Stephen P. Wren、Graham M. Wynne

  DOI：10.1021/jm200135z

  日期：2011.5.12

  A series of novel 2-arylbenzoxazoles that upregulate the production of utrophin in murine H2K cells, as assessed using a luciferase reporter linked assay, have been identified. This compound class appears to hold considerable promise as a potential treatment for Duchenne muscular dystrophy. Following the delineation of structure-activity relationships in the series, a number of potent upregulators were identified, and preliminary ADME evaluation is described. These studies have resulted in the identification of 1, a compound that has been progressed to clinical trials.
• Hit to lead SAR study on benzoxazole derivatives for an NPY Y5 antagonist
  作者：Naoki Omori、Naoki Kouyama、Akira Yukimasa、Kana Watanabe、Yasunori Yokota、Hideki Tanioka、Hirohide Nambu、Hideo Yukioka、Norihito Sato、Yukari Tanaka、Kazutaka Sekiguchi、Takayuki Okuno

  DOI：10.1016/j.bmcl.2012.01.027

  日期：2012.3

  We report a hit to lead study on a novel benzoxazole NPY Y5 antagonist. Starting from HTS hit 1, structure-activity relationships were developed. Compound 12 showed reduction of food intake and a tendency to suppress body weight gain over the 21-day experimental period. (C) 2012 Elsevier Ltd. All rights reserved.